Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.
Open Access
- 1 December 1997
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 100 (11), 2783-2792
- https://doi.org/10.1172/jci119825
Abstract
Mucin 1 (MUC1) is a large complex glycoprotein that is highly expressed in breast cancer, and as such could be a target for immunotherapy. In mice, human MUC1 is highly immunogenic, particularly when conjugated to mannan, where a high frequency of CD8(+) MHC-restricted cytotoxic T lymphocytes is induced, accompanied by tumor protection. On this basis, a clinical trial was performed in which 25 patients with advanced metastatic carcinoma of breast, colon, stomach, or rectum received mannan-MUC1 in increasing doses. After 4 to 8 injections, large amounts of IgG1 anti-MUC1 antibodies were produced in 13 out of 25 patients (with antibody titers by ELISA of 1/320-1/20,480). Most of the antibodies reacted to the epitopes STAPPAHG and PAPGSTAP. In addition, T cell proliferation was found in 4 out of 15 patients, and CTL responses were seen in 2 out of 10 patients. Mannan-MUC1 can immunize patients, particularly for antibody formation, and to a lesser extent, cellular responses. It remains to be seen whether such responses have antitumor activity.Keywords
This publication has 50 references indexed in Scilit:
- Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patientsBritish Journal of Cancer, 1995
- HLA A2601-restricted CTLs recognize a peptide antigen expressed on squamous cell carcinoma.1995
- Epithelial Mucin GenesAnnual Review of Physiology, 1995
- MHC ligands and peptide motifs: first listingImmunogenetics, 1995
- Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A).Proceedings of the National Academy of Sciences of the United States of America, 1995
- The Pathogenesis of Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1994
- Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.1994
- Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.The Journal of Immunology, 1994
- Cellular Mucins: Targets for ImmunotherapyCritical Reviews in Immunology, 1994
- Monitoring of solid phase peptide synthesis by an automated spectrophotometric picrate methodAnalytical Biochemistry, 1975